Word

LIGHTBIO

Status

Registered

Status Code

700

Status Date

Tuesday, June 8, 2021

Serial Number

79279617

Registration Number

6375045

Registration Date

Tuesday, June 8, 2021

Mark Type

4000

Filing Date

Wednesday, August 28, 2019

Published for Opposition

Tuesday, March 23, 2021

Trademark Owner History

LightBio Limited - Original Registrant

Classifications

1 Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in scientific research in the field of agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labelling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; Nucleic acids comprising natural and unnatural nucleotides for laboratory use; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for laboratory use; composites of nucleic acids or nucleic acid analogues with organic and NAC inorganic chemicals for laboratory use; all the aforesaid goods for use in laboratory nanotechnology applications, namely, data storage, data retrieval and computing

5 Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labeling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds

9 Scientific apparatus and instruments, namely, apparatus for amplifying DNA, namely, reactors and bioreactors; apparatus for manufacturing DNA, namely, reactors and bioreactors; apparatus for processing DNA, namely, reactors and bioreactors; electronic components, namely, nucleic acid analogues in the nature of electric and power wires, semi-conductors, transistors, rectifiers, diodes, light emitting diodes and energy storage systems in the nature of devices for energy storage, namely, batteries, fuel cells configured for energy storage, and electrochemical devices configured for energy storage, namely, electrolysers; electric and power wires comprised of nucleic acid composites (NACs) semi-conductors, transistors, rectifiers, diodes, light emitting diodes and energy storage systems in the nature of devices for energy storage, namely, batteries, fuel cells configured for energy storage, and electrochemical devices configured for energy storage, namely, electrolysers, each comprised of nucleic acid composites (NACs); labeling, imaging and sensing apparatus comprising of nucleic acid composites (NACs) for laboratory and research use; smart materials in the nature of DNA chips, DNA microarrays, comprised of nucleic acid composites; two-dimensional and three-dimensional nucleic acid composites (NACs) in the nature of DNA chips, DNA microarrays for creating nanostructures and scaffolds for use in electronic components and materials, namely, electrical conductors; parts and fittings for all the aforesaid technology and parts and fittings for all the aforesaid goods, namely, electrical cables, display screens, transmitters

40 Chemical treatment of DNA to form DNA extracts; custom manufacture of therapeutic DNA by the manipulation of DNA into DNA extracts or cassettes

42 Scientific and technological services and research and design relating thereto, namely, chemical and biological analysis and research services; DNA analysis services for scientific research purposes; scientific research and development into the creation of DNA extracts; scientific research, analysis, design and development relating to DNA based drugs and therapies; scientific research and development in the fields of gene therapy, genetic diagnostics, agri-biotechnology and nanotechnology, all in the field of gene therapy; consultancy relating to the aforesaid services

LIGHT BIO

Trademark Events

Oct 24, 2021

Final Decision Transaction Processed By Ib

Sep 28, 2021

Final Disposition Notice Sent To Ib

Sep 28, 2021

Final Disposition Processed

Sep 8, 2021

Final Disposition Notice Created, To Be Sent To Ib

Jun 8, 2021

Registered-Principal Register

Mar 23, 2021

Official Gazette Publication Confirmation E-Mailed

Mar 23, 2021

Published For Opposition

Mar 21, 2021

Notification Processed By Ib

Mar 3, 2021

Notification Of Possible Opposition Sent To Ib

Mar 3, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 3, 2021

Notification Of Notice Of Publication E-Mailed

Feb 16, 2021

Approved For Pub - Principal Register

Feb 16, 2021

Examiner's Amendment Entered

Feb 16, 2021

Notification Of Examiners Amendment E-Mailed

Feb 16, 2021

Examiners Amendment E-Mailed

Feb 16, 2021

Examiners Amendment -Written

Feb 11, 2021

Teas/Email Correspondence Entered

Feb 11, 2021

Correspondence Received In Law Office

Feb 11, 2021

Teas Request For Reconsideration Received

Jan 7, 2021

Notification Of Final Refusal Emailed

Jan 7, 2021

Final Refusal E-Mailed

Jan 7, 2021

Final Refusal Written

Dec 17, 2020

Teas/Email Correspondence Entered

Dec 17, 2020

Correspondence Received In Law Office

Dec 15, 2020

Assigned To Lie

Sep 21, 2020

Teas Response To Office Action Received

Apr 10, 2020

Refusal Processed By Ib

Mar 25, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Mar 25, 2020

Refusal Processed By Mpu

Mar 6, 2020

Application Filing Receipt Mailed

Mar 4, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Mar 3, 2020

Non-Final Action Written

Mar 2, 2020

Assigned To Examiner

Mar 2, 2020

New Application Office Supplied Data Entered In Tram

Feb 27, 2020

Sn Assigned For Sect 66a Appl From Ib